FDA Publishes Draft Guidance On Psychedelic Drug Research
The U.S. Food and Drug Administration on Friday published a new draft guidance highlighting considerations researchers should take into account while investigating the use of psychedelic drugs like psilocybin for treatment...To view the full article, register now.
Already a subscriber? Click here to view full article